However, the combination of Merck's approved doravirine and investigational islatravir didn't prove superiority over Gilead's ...

The FDA is elevating a recall from Boston Scientific covering its cryoablation balloon catheters for the treatment of atrial ...

Omeros is putting up its monoclonal antibody up for FDA approval—again. | Omeros is putting up its monoclonal antibody up for ...

Vertex has reported a phase 2 win that still dented confidence in its pain prospect suzetrigine. The trial linked the ...

Two months after former Seagen CEO David Epstein unveiled his new project, the biotech has secured "over" $140 million in ...

KdT Ventures has signed off on a $608 million biobucks dea l for NGM Biopharmaceuticals’ phase 2-ready metabolic-dysfunction ...

Bristol Myers Squibb has turned to the source of Leqembi to further its push into Alzheimer’s disease, paying BioArctic $100 ...

After its rare disease drug was rejected by the FDA in late November, Applied Therapeutics vowed to fight on with a ...

Astellas is continuing to strengthen its neurological disease gene therapy capabilities, handing Sangamo Therapeutics $20 ...

Back-to-back clinical failures have dealt further blows to efforts to treat Parkinson’s disease by targeting alpha-synuclein.

Italian VC XGEN Venture has closed a 180 million euro ($190 million) fund for biotech and medtech companies. | Italian VC ...

Amid reports of the first severe human case of bird flu in the U.S., Labcorp has launched a molecular diagnostic test for the H5N1 virus. | According to the clinical testing giant, its H5N1 test can ...